Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism ROCK1 inhibitors(Rho-associated protein kinase 1 inhibitors), ROCK2 inhibitors(Rho-associated protein kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H15N3O2S |
InChIKeyPDDRNTYAGWVWRY-XDHOZWIPSA-N |
CAS Registry2250054-81-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | Brazil | 25 Jul 2018 |